XELJANZ 5MG TABLET

Xeljanz 5mg tablet has the active ingredient Tofacitinib. It is a DMARD, or disease-modifying anti-rheumatoid (DMARD), which belongs to the class of immunomodulators. It can be used by itself or with other medications to treat rheumatoid arthritis (A disease in which the body attacks joints, which causes pain, swelling, and impairment of function) for people ineligible to take or respond to other medicines. It can also be utilized to manage psoriatic arthritis (A condition that causes joint pain, swelling, and scales over the body). It can also treat adult patients suffering from moderately active to severe ulcerative colitis.
Other uses for Xeljanz 5mg tablet are ankylosing spondylitis (inflammatory condition of the spine). It can also be utilized to treat active polyarticular juvenile idiopathic arthritis. It is an ongoing condition most commonly responsible for swelling and joint pain in patients who are two years old or older. The medication works by reducing the activities in the body’s immune system. Inform your doctor if you are suffering from severe tuberculosis, blood infection, or liver issues. Inform your physician if you ever had or are suffering from a chronic hepatitis B infection, as this medication can trigger the condition known as hepatitis B to reactivate.
Do not consume Xeljanz 5 mg tablet if you are sensitive to tofacitinib or other components of this medication. Contact your doctor when you experience any indications of an infection, including sweating, fever, chills, muscle aches or coughing breath shortness skin sores, weight loss, pain di, difficulty swallowing, diarrhea, or stomach discomfort. Before beginning treatment, let your doctor know whether you suffer from kidney or heart, lung or liver issues, a diagnosis of tuberculosis, high blood pressure, or high cholesterol. Also, inform your doctor whether you are a current or former smoker.